Could a cancer drug help long COVID sufferers? new trial aims to find out
Symptom relief
Recruiting now
This study tests whether plitidepsin, a drug given by IV, can improve overall health in adults with moderate to severe long COVID symptoms. About 90 people will receive either the drug or a placebo over four treatment cycles (one every two weeks), then be followed for 90 days. Th…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated May 07, 2026 18:39 UTC